News | October 31, 2011

Accuray Announces Rapid Clinical Adoption of TomoDirect Treatment Delivery Mode

 

October 31, 2011 – Accuray announced that more than 100 of its TomoDirect treatment modality systems are now in use at leading cancer centers throughout the world, offering patients the option of treatment with image-guided, intensity-modulated radiation therapy (IG-IMRT) for routine radiation therapy indications.

First delivered to the market in 2010, TomoDirect is a standard feature on the TomoHD treatment system. It is optimized for delivering radiation at fixed angles, making it highly efficient for whole breast radiotherapy and other cases where select beam angles are most appropriate. Global adoption continues, with over 75 percent of system orders in the past six months including TomoDirect.

The Institute for Image-Guided RadioThereapy (IIGRT), in Westchester, Rye, N.Y., is one of the first centers in the world to offer TomoDirect treatments. IIGRT performs both whole breast and accelerated partial breast irradiation (APBI) with TomoDirect.

"IIGRT has been using the TomoTherapy System since 2007 and we have significantly increased our treatment capacity with the addition of TomoDirect last year, because we can now offer TomoTherapy to an expanded patient population," said Daniel Fass, M.D., director of IIGRT. "TomoDirect offers a highly accurate and convenient method for delivering APBI. This allows us to offer many breast cancer patients a shorter course of high quality radiation therapy treatments. We also use TomoDirect for conventional breast treatments when it offers a dosimetric advantage over Helical TomoTherapy."

Accuray's TomoHD Treatment System is a comprehensive solution that efficiently handles clinical indications of any complexity. The system offers both TomoDirect and TomoHelical treatment modes to allow clinicians to deliver treatment options for a range of clinical indications and enables daily 3-D computed tomography (CT) imaging of every patient, prior to each treatment, to maximize treatment accuracy. The TomoDirect modality is efficient in applying multiple targeted radiation beams to the tumor for more routine cases while TomoHelical is designed for more complex cases, delivering radiation throughout multiple 360-degree gantry rotations.

For more information: www.accuray.com

 

October 31, 2011 – Accuray announced that more than 100 of its TomoDirect treatment modality systems are now in use at leading cancer centers throughout the world, offering patients the option of treatment with image-guided, intensity-modulated radiation therapy (IG-IMRT) for routine radiation therapy indications.

First delivered to the market in 2010, TomoDirect is a standard feature on the TomoHD treatment system. It is optimized for delivering radiation at fixed angles, making it highly efficient for whole breast radiotherapy and other cases where select beam angles are most appropriate. Global adoption continues, with over 75 percent of system orders in the past six months including TomoDirect.

The Institute for Image-Guided RadioThereapy (IIGRT), in Westchester, Rye, N.Y., is one of the first centers in the world to offer TomoDirect treatments. IIGRT performs both whole breast and accelerated partial breast irradiation (APBI) with TomoDirect.

"IIGRT has been using the TomoTherapy System since 2007 and we have significantly increased our treatment capacity with the addition of TomoDirect last year, because we can now offer TomoTherapy to an expanded patient population," said Daniel Fass, M.D., director of IIGRT. "TomoDirect offers a highly accurate and convenient method for delivering APBI. This allows us to offer many breast cancer patients a shorter course of high quality radiation therapy treatments. We also use TomoDirect for conventional breast treatments when it offers a dosimetric advantage over Helical TomoTherapy."

Accuray's TomoHD Treatment System is a comprehensive solution that efficiently handles clinical indications of any complexity. The system offers both TomoDirect and TomoHelical treatment modes to allow clinicians to deliver treatment options for a range of clinical indications and enables daily 3-D computed tomography (CT) imaging of every patient, prior to each treatment, to maximize treatment accuracy. The TomoDirect modality is efficient in applying multiple targeted radiation beams to the tumor for more routine cases while TomoHelical is designed for more complex cases, delivering radiation throughout multiple 360-degree gantry rotations.

For more information: www.accuray.com

 

Related Content

New Prostate Cancer Radiotherapy Technique Aims to Preserve Sexual Function
News | Radiation Therapy | June 18, 2018
A multicenter clinical trial being led by UT Southwestern physicians is testing a technique for sparing nerve bundles...
Elekta Unity High-Field MR-Linac Receives CE Mark
News | Image Guided Radiation Therapy (IGRT) | June 18, 2018
Elekta announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received CE mark,...
Washington University in St. Louis Begins Clinical Treatments With ViewRay MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | June 14, 2018
June 14, 2018 — The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in S
Accuray TomoTherapy System Beneficial in Two Total Body Irradiation Studies
News | Radiation Therapy | June 13, 2018
Recently published data from two new studies demonstrate the benefits of Accuray’s TomoTherapy System in the delivery...
IsoRay Funding Brain Cancer Treatment Research With Ochsner Clinic Foundation
News | Brachytherapy Systems | June 12, 2018
IsoRay Inc. announced the initiation of research funding for brain cancer treatment to Ochsner Clinic Foundation, a not...
News | Brachytherapy Systems | June 07, 2018
IsoRay Inc. announced the upcoming release of its Build-Blu delivery system for real-time prostate brachytherapy.
Raysearch RayStation
Feature | Radiation Therapy | June 05, 2018 | By Melinda Taschetta-Millane
Treatment planning systems are at the heart of r...
Beaumont Researchers Invent New Mode of Proton Treatment for Lung Cancer
News | Proton Therapy | May 31, 2018
Members of Beaumont Health’s proton therapy team presented research on a new treatment for patients with lung cancer at...
More Than 60 Percent of Patients Seeking Proton Therapy Initially Denied Coverage
News | Proton Therapy | May 25, 2018
The Alliance for Proton Therapy Access has released a national report revealing the heavy emotional and financial...
News | Treatment Planning | May 24, 2018
Daniela Schmitt, Ph.D., took top honors in the overall category of the 2018 TROG Plan Study: Stereotactic Radiosurgery...
Overlay Init